Novo Nordisk has cut its forecast for the fourth time this year, after disappointing sales of its blockbuster drugs Wegovy and Ozempic. It underscores the challenges facing its new chief executive Mike Doustdar. He spoke to Bloomberg's Guy Johnson about the experience so far. 

 

Novo Nordisk has cut its forecast for the fourth time this year, after disappointing sales of its blockbuster drugs Wegovy and Ozempic.&nbsp;It underscores the challenges facing its new chief executive Mike Doustdar.&nbsp;He spoke to Bloomberg's Guy Johnson about the experience so far.&nbsp;
&nbsp;

Listen for top interviews from Bloomberg News. 

Hear conversations with the biggest names in finance, politics, technology, foreign relations, sports and entertainment.

Listen for top interviews from Bloomberg News. Hear conversations with the biggest names in finance, politics, technology, foreign relations, sports and entertainment.

Listen to top interviews from Bloomberg News.

Bloomberg Talks

Novo Nordisk CEO Mike Doustdar Talks Drug Sales 

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/2d7de441-899b-4fa7-9e22-b38c00a0570f/transcript

T. Rowe Price CEO Rob Sharps discusses how the company is adapting to the rise of passive investing. Speaking with Romaine Bostick, Sharps also says private assets are slowly moving into 401(k) plans and sees "tax-loss harvesting" as a growth area. He also discusses how the firm is utilizing artificial intelligence.

T. Rowe Price CEO Rob Sharps discusses how the company is adapting to the rise of passive investing. Speaking with Romaine Bostick, Sharps also says private assets are slowly moving into 401(k) plans and sees "tax-loss harvesting" as a growth area. He also discusses how the firm is utilizing artificial intelligence.

T. Rowe Price CEO Rob Sharps Talks Private Assets and AI Adoption

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/5077d3f4-2755-4780-823b-b4b7015ec55d/transcript

Kalshi banned Ex-Congressman George Santos for life for allegedly manipulating wagers on his attendance at this year’s State of the Union address. Santos was also fined $71,356 by Kalshi, which announced the action after he didn’t cooperate with their probe into the case. The ban follows Santos settling a federal regulator’s probe that included fines, penalties and a three-year ban, related to claims he made material misrepresentations and omissions on social media.

For more, Bloomberg's Tim Stenovec and Kristine Aquino speak with Brian Quintenz, Kalshi Board Member and Former CFTC Commissioner

Kalshi banned Ex-Congressman George Santos for life for allegedly manipulating wagers on his attendance at this year&rsquo;s State of the Union address.&nbsp;Santos was also fined $71,356 by Kalshi, which announced the action after he didn&rsquo;t cooperate with their probe into the case.&nbsp;The ban follows Santos settling a federal regulator&rsquo;s probe that included fines, penalties and a three-year ban, related to claims he made material misrepresentations and omissions on social media.
For more, Bloomberg's Tim Stenovec and Kristine Aquino speak with Brian Quintenz, Kalshi Board Member and Former CFTC Commissioner

Kalshi's Brian Quintenz Talks George Santos Lifetime Ban

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/12632508-3040-4df2-83df-b4b70134e2e1/transcript

Nvidia is investing $3.5 billion in MediaTek, deepening collaboration with the Taiwanese chipmaker at a time when it’s working to persuade more companies to build chips that plug into its dominant data center ecosystem.

Nvidia CEO Jensen Huang and MediaTek CEO Rick Tsai join Bloomberg Tech's Ed Ludlow to discuss the deal.

Nvidia is investing $3.5 billion in MediaTek, deepening collaboration with the Taiwanese chipmaker at a time when it&rsquo;s working to persuade more companies to build chips that plug into its dominant data center ecosystem.
Nvidia CEO Jensen Huang and MediaTek CEO Rick Tsai join Bloomberg Tech's Ed Ludlow to discuss the deal.

Nvidia CEO Jensen Huang & MediaTek CEO Rick Tsai Talk New Partnership

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/30be3b09-c4d3-401f-a783-b4b700e5da7c/transcript

Novo Nordisk CEO Mike Doustdar Talks Drug Sales

In 1 playlist(s)

Bloomberg Talks

Social links

Follow podcast

Recent clips